NCT04470388View on ClinicalTrials.gov

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions
Chronic HBV Infection
Interventions
DRUG

EDP-514

Oral Capsule

DRUG

Placebo

Placebo to match EDP-514

Trial Locations (10)

100229

National Taiwan University Hospital, Taipei

333423

Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan District

404332

China Medical University Hospital, Taichung

500209

Changhua Christian Hospital, Changhua

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

600566

Chia-Yi Christian Hospital, Chiayi City

704302

National Cheng Kung University Hospital, Tainan City

824410

E-Da Hospital/E-DA Cancer Hospital, Kaohsiung City

833401

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Unknown

Queen Mary Hospital, Hong Kong

Sponsors
All Listed Sponsors
collaborator

Pharmaceutical Research Associates

OTHER

lead

Enanta Pharmaceuticals, Inc

INDUSTRY